While the Government’s $37 million Covid-19 vaccine strategy includes $22m for international vaccine alliances, which advocate fair distribution, reality doesn't always live up to the idealistic talk. They recently took over an adjoining cell culture facility, which chief executive Nidish Nair said could be dedicated to Covid-19 vaccine manufacturing. BioCell has already teamed up with British company Stabilitech to make its Covid-19 vaccine for trials set to begin this year. Sakchai Lalit/AP There are not enough vials in the world to make sufficient Covid-19 vaccine doses to meet global demand. That was a criticism of this year's flu vaccine rollout – that practices with lots of high-risk patients were not prioritised.

Source: Stuff July 09, 2020 17:00 UTC